Taro Receives FDA Approval Of New Drug Application For Flo-Pred(TM) (Prednisolone Acetate Oral Suspension) (Medical News Today)
Taro Pharmaceutical Industries Ltd. (the "Company" or "Taro," Pink Sheets: TAROF) reported that its U.S. affiliate, Taro Pharmaceuticals U.S.A., Inc. ("Taro USA") has received approval from the U.S.

Banner Pharmacaps Receives FDA Approval For Nimodipine Softgel Capsules (Medical News Today)
Banner Pharmacaps Inc., a leader in the pharmaceutical industry for the development of soft gelatin dosage form technology, announced that the US Food & Drug Administration has granted approval for the Company's Abbreviated New Drug Application (ANDA) for Nimodipine 30 mg soft gelatin capsules.

Xanthus Announces Oral Fludarabine NDA Accepted For Review By U.S. FDA (Medical News Today)
Xanthus Pharmaceuticals, Inc., a privately-held oncology and autoimmune disease drug development company, announced that its New Drug Application (NDA) for fludarabine phosphate oral tablets (oral fludarabine) was accepted for filing by the U.S. Food and Drug Administration (FDA) for the treatment of relapsed B-cell chronic lymphocytic leukemia (CLL).